Growth Of Specialty Pharma Draws Generics Litigation
As specialty pharmaceutical companies expand their foothold in the pharmaceutical arena, their drugs for niche markets are becoming much more susceptible to patent litigation with aggressive generics companies....To view the full article, register now.
Already a subscriber? Click here to view full article